Tag: Evolut Pro
Clinical outcomes similar at one-year for leading TAVI platforms in real-world registry, but stroke rates differ
A comparison of two latest-generation self-expanding and balloon-expandable transcatheter aortic...
ADVERTORIAL: Evolut PRO+ provides options in the toughest TAVI cases
This advertorial is sponsored by Medtronic.
Evolut PRO+ is the latest generation of self-expandin...
Evolut gets CE mark in low-risk patients and new labelling for bicuspid use
Medtronic has been awarded CE mark for the use of the Evolut transcatheter aortic valve implanta...
Bicuspid TAVI outcomes as good as those for tricuspid
Clinical and echocardiographic outcomes at 30 days and one year were similar between patients wi...
FDA approves Evolut PRO+
The US Food and Drug Administration (FDA) has approved the Evolut PRO+ transcatheter aortic valv...
TAVI pacemaker issue is “an engineering problem that will be solved”
The SURTAVI trial indicates that transcatheter aortic valve implantation (TAVI) with CoreValve/...
ACC 2017: FDA approves launch of CoreValve Evolut Pro
The FDA has approved Medtronic’s CoreValve Evolut Pro transcatheter aortic valve implantation (T...
